The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Invesco Mutual Fund, through seven of its schemes, bought 1,43,820 equity shares of Sai Life Sciences in the open market on October 13, 2025. The acquisition took its aggregate holding from 7.2091% to 7.2777% of paid-up share capital — a 0.0685% bump in this single transaction, but a cumulative 2.0685% rise from its earlier disclosure, which is why this Reg 29(2) filing has been triggered. The acquirer is not part of the promoter group, and the transaction involved no encumbrance, warrants, or off-market dealing. Total paid-up capital of the company remained unchanged at ~20.98 crore shares of Re. 1 each.
A mild uptick in institutional (FII) ownership — broadly a sentiment-positive signal, but the move is too small to materially shift the stock. Invesco is now just under the 7.5% mark and well short of the 10% FII disclosure threshold, leaving room for further accumulation without an immediate regulatory flashpoint.